➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Moodys
Express Scripts
Johnson and Johnson
Dow

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Pegvisomant - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for pegvisomant

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Phase 3
St. Michael's Hospital, TorontoPhase 3
NovartisPhase 4

See all pegvisomant clinical trials

Recent Litigation for pegvisomant

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Supernus Pharmaceuticals, Inc v. Actavis Inc.2016-02-24

See all pegvisomant litigation

Patent Text Search: US Patents for pegvisomant

These patents were identified by searching patent claims

Supplementary Protection Certificates for pegvisomant

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2006000003 Germany   Start Trial PRODUCT NAME: WIRKSTOFFZUSAMMENSETZUNG UMFASSEND PEGVISOMANT; REGISTRATION NO/DATE: EU/1/02/240/001-003 20021113
C0043 France   Start Trial PRODUCT NAME: PEGVISOMANT; REGISTRATION NO/DATE: EU/1/02/240/001-003 20021113
05C/037 Belgium   Start Trial PRODUCT NAME: PEGVISOMANT; AUTHORISATION NUMBER AND DATE: EU/1/02/240/001 20021115
/2005 Austria   Start Trial PRODUCT NAME: PEGVISOMANT; REGISTRATION NO/DATE: EU/1/02/240/001 - 003 20021113
0210 Netherlands   Start Trial PRODUCT NAME: PEGVISOMANT; NATIONAL REGISTRATION NO/DATE: EU/1/02/240/002 20021115; FIRST REGISTRATION: EU EU/1/02/240/001 20021115
43/2005 Austria   Start Trial PRODUCT NAME: PEGVISOMANT
C/GB05/047 United Kingdom   Start Trial PRODUCT NAME: PEGVISOMANT, OPTIONALLY IN THE FORM OF A PEGYLATION VARIANT; REGISTERED: UK EU/1/02/240/001 20021115; UK EU/1/02/240/002 20021115; UK EU/1/02/240/003 20021115
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.